Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Treasury Shares (2020 - 2025)

Outset Medical has reported Treasury Shares over the past 6 years, most recently at $203000.0 for Q4 2025.

  • Quarterly Treasury Shares rose 109.28% to $203000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $203000.0 through Dec 2025, up 109.28% year-over-year, with the annual reading at $203000.0 for FY2025, 109.28% up from the prior year.
  • Treasury Shares was $203000.0 for Q4 2025 at Outset Medical, up from $97000.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $1.6 million in Q4 2022 and troughed at $97000.0 in Q4 2024.
  • The 5-year median for Treasury Shares is $432000.0 (2023), against an average of $577600.0.
  • Year-over-year, Treasury Shares skyrocketed 1179.55% in 2021 and then crashed 77.55% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $563000.0 in 2021, then soared by 182.95% to $1.6 million in 2022, then tumbled by 72.88% to $432000.0 in 2023, then crashed by 77.55% to $97000.0 in 2024, then soared by 109.28% to $203000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Treasury Shares are $203000.0 (Q4 2025), $97000.0 (Q4 2024), and $432000.0 (Q4 2023).